Journal of Antivirals & Antiretrovirals : Citations & Metrics Report
Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
59 | 57 | 32 | 59 | 77 | 13 | 11 | 20 | 37 | 22 | 37 | 55 | 22 | 12 |
Research, Review articles and Editorials |
1 | 0 | 5 | 42 | 32 | 12 | 10 | 14 | 27 | 21 | 33 | 44 | 21 | 10 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
48 | 57 | 27 | 17 | 45 | 1 | 1 | 6 | 10 | 1 | 4 | 11 | 1 | 2 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 35 | 51 | 125 | 100 | 191 | 0 | 125 | 177 |
Citations received as per Google Scholar, other indexing platforms and portals |
98 | 160 | 172 | 269 | 223 | 172 | 219 | 195 | 170 | 116 | 60 | 36 | 26 | 58 |
Journal total citations count | 2004 |
Journal impact factor | 5.32 |
Journal 5 years impact factor | 5.62 |
Journal cite score | 5.3 |
Journal h-index | 22 |
Journal h-index since 2019 | 17 |
Important citations (1101)
Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus |
|
Recombinant monoclonal antibodies for rabies postexposure prophylaxis |
|
Syn023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies |
|
In vivo efficacy of a cocktail of human monoclonal antibodies (cl184) against diverse north american bat rabies virus variants |
|
Comparison of a novel human rabies monoclonal antibody to human rabies immunoglobulin for postexposure prophylaxis: a phase 2/3, randomized, single-blind, noninferiority, controlled study |
|
Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: a review of the current status of the clinical development pipeline |
|
Task force report: european respiratory society guidelines for the management of children and adolescents with bronchiectasis |
|
Clinical and research priorities for children and young people with bronchiectasis: an international roadmap |
|
Macrolide antibiotics for non?cystic fibrosis bronchiectasis |
|
Prevention of exacerbations in patients with stable non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis of pharmacological and non-pharmacological therapies |
|
Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis |
|
Non-cystic fibrosis bronchiectasis in children and adolescents: neglected and emerging issues |
|
Macrolide antibiotics for bronchiectasis |
|
Prolonged antibiotics for non?cystic fibrosis bronchiectasis in children and adults |
|
Prolonged antibiotics for purulent bronchiectasis in children and adults |
|
Airway clearance techniques for bronchiectasis |
|
Risk assessment and anti-viral approaches for novel h7n9 influenza virus |
|
A review of medicinal plants with antiviral activity available in bangladesh and mechanistic insight into their bioactive metabolites on sars-cov-2, hiv and hbv |
|
Review of antiviral activities present in some indian medicinal plants – can they be used against sarscov-2? |
|
Clove essential oil (syzygium aromaticum l. myrtaceae): extraction, chemical composition, food applications, and essential bioactivity for human health |
|